StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
70
This month
4
This year
18
Publishing Date
2024 - 01 - 26
1
2024 - 01 - 25
1
2024 - 01 - 24
1
2024 - 01 - 23
1
2024 - 01 - 22
1
2024 - 01 - 16
2
2024 - 01 - 15
1
2024 - 01 - 12
1
2024 - 01 - 11
1
2024 - 01 - 10
1
2024 - 01 - 02
1
2023 - 12 - 20
1
2023 - 12 - 13
1
2023 - 12 - 12
1
2023 - 12 - 06
2
2023 - 11 - 30
1
2023 - 11 - 28
1
2023 - 11 - 21
1
2023 - 11 - 15
1
2023 - 11 - 14
2
2023 - 11 - 08
1
2023 - 10 - 18
1
2023 - 09 - 20
1
2023 - 08 - 22
1
2023 - 07 - 21
1
2023 - 07 - 03
1
2023 - 06 - 26
1
2023 - 06 - 21
1
2023 - 06 - 19
1
2023 - 05 - 09
1
2023 - 05 - 08
1
2023 - 05 - 03
1
2023 - 04 - 14
1
2023 - 03 - 02
1
2023 - 01 - 12
1
2022 - 11 - 04
1
2022 - 05 - 23
1
2022 - 05 - 10
1
2022 - 03 - 08
1
2022 - 03 - 01
1
2022 - 02 - 28
1
2022 - 02 - 07
1
2021 - 12 - 03
1
2021 - 12 - 01
1
2021 - 11 - 11
1
2021 - 11 - 04
1
2021 - 09 - 28
1
2021 - 09 - 16
2
2021 - 08 - 30
1
2021 - 08 - 19
1
2021 - 08 - 09
1
2021 - 08 - 05
1
2021 - 08 - 02
1
2021 - 07 - 21
1
2021 - 06 - 17
1
2021 - 06 - 16
1
2021 - 06 - 03
1
2021 - 06 - 01
1
2021 - 05 - 12
1
2021 - 05 - 06
1
Sector
Commercial services
1
Electronic technology
2
Finance
1
Health services
3
Health technology
70
Manufacturing
6
Non-energy minerals
1
Process industries
1
Technology services
1
Tags
Acquire
1
Acquired
1
Acquisition
1
Advanced
1
Agreement
1
America
2
Antibody
1
Association
1
Authorized
3
Biocanada
1
Biomarker
1
Biomidwest
2
Biopharma
3
Bioscience
3
Biotech-beach
6
Biotechnology
1
Breast
1
Cancer
10
Cardiovascular
1
Cell
1
Ces
1
Children
1
Clinical-trials-phase-iii
1
Colorectal cancer
1
Companies
4
Conference
2
Corporation
1
Covid
3
Diabetes
4
Diabetic
1
Disease
2
Drug
6
Earnings
2
Emergency use authorization
2
Ev
1
Events
2
Fda
3
Financial results
7
Global
10
Growth
19
Jardiance
2
Key
3
Liver
2
Market
28
Meeting
2
Merge
3
Money
2
N/a
46
Obesity
2
Pharmaceuticals
2
Positive
3
Report
7
Research
6
Results
12
Show
2
Study
9
Therapeutics
2
Therapy
5
Treatment
10
Trial
3
Entities
89bio, inc.
1
Abbott laboratories
3
Abbvie inc.
4
Abcellera biologics inc
2
Adverum biotechnologies, inc.
1
Aldeyra therapeutics, inc.
1
Alnylam pharmaceuticals, inc.
3
Altimmune, inc.
1
Amgen inc.
5
Applied genetic technologies corporation
1
Arcellx, inc.
1
Astellas pharma inc
1
Astrazeneca plc
2
Avantor, inc.
1
Aveo pharmaceuticals, inc.
1
Avidity biosciences, inc.
3
Beam therapeutics inc.
1
Beigene, ltd.
1
Bio-rad laboratories, inc.
1
Bluebird bio, inc.
1
Blueprint medicines corporation
1
Boston scientific corporation
1
Bristol-myers squibb company
1
Cardiff oncology, inc.
1
Cardiovascular systems, inc.
1
Ceva, inc.
1
Chinook therapeutics, inc.
1
Cyteir therapeutics inc
1
Dice therapeutics, inc.
1
Eli lilly and company
70
Ellington financial inc.
1
Evofem biosciences, inc.
1
Evotec se
3
Galapagos nv
1
Gilead sciences, inc.
2
Glaxosmithkline plc
4
Goodrx holdings, inc.
1
Great ajax corp.
1
Hepion pharmaceuticals, inc.
1
I-mab
2
Icon plc
1
Immune therapeutics, inc.
1
Immunome, inc.
1
Incyte corporation
2
Iqvia holdings, inc.
1
Johnson & johnson
9
Kiniksa pharmaceuticals, ltd.
1
Koninklijke philips n.v.
2
Ligand pharmaceuticals incorporated
1
Madrigal pharmaceuticals, inc.
1
Merus n.v.
2
Metacrine, inc.
1
Mirati therapeutics, inc.
1
Novartis ag
6
Novo nordisk a/s
5
Pfizer, inc.
2
Point biopharma global inc
2
Sanofi
17
Terumo corp
2
Vertex pharmaceuticals incorporated
2
Symbols
AAPL
45
ABB
62
ABBNY
32
ABBV
37
ABLZF
49
ABT
80
ACAQ
51
AEM
40
AMGN
47
ARVL
157
AUY
33
BDX
37
CLLS
37
CNS
47
CNXC
36
DELL
31
DHR
40
DOV
37
ENB
32
ERIC
36
EXPR
31
FNCTF
303
FRBA
44
FST
41
GE
37
GIC
31
GLAXF
35
GOOG
51
GOOGL
51
GSK
49
HON
63
HUBS
58
JNJ
167
LLY
70
LMNR
39
LTUM
47
MDT
46
MFC
64
MMM
38
MS
302
NBR
34
NDAQ
50
NVDA
37
NVS
56
NVSEF
44
OOMA
68
ORCL
32
PPRUF
41
PPRUY
41
SAP
45
SLG
39
SNOW
52
SNY
161
SNYNF
132
SRE
34
TMO
67
VSAC
46
WPM
38
WSFS
48
XYF
60
Exchanges
Nasdaq
52
Nyse
70
Crawled Date
2024 - 01 - 26
1
2024 - 01 - 25
1
2024 - 01 - 24
1
2024 - 01 - 23
1
2024 - 01 - 22
1
2024 - 01 - 16
2
2024 - 01 - 15
1
2024 - 01 - 12
1
2024 - 01 - 11
1
2024 - 01 - 10
1
2024 - 01 - 02
1
2023 - 12 - 20
1
2023 - 12 - 13
1
2023 - 12 - 12
1
2023 - 12 - 06
2
2023 - 11 - 30
1
2023 - 11 - 28
1
2023 - 11 - 21
1
2023 - 11 - 15
1
2023 - 11 - 14
2
2023 - 11 - 08
1
2023 - 10 - 18
1
2023 - 09 - 20
1
2023 - 08 - 22
1
2023 - 07 - 21
1
2023 - 07 - 03
1
2023 - 06 - 26
1
2023 - 06 - 21
1
2023 - 06 - 19
1
2023 - 05 - 09
1
2023 - 05 - 08
1
2023 - 05 - 03
1
2023 - 04 - 14
1
2023 - 03 - 02
1
2023 - 01 - 12
1
2022 - 11 - 04
1
2022 - 05 - 23
1
2022 - 05 - 10
1
2022 - 03 - 08
1
2022 - 03 - 01
1
2022 - 02 - 28
1
2022 - 02 - 07
1
2021 - 12 - 03
1
2021 - 12 - 01
1
2021 - 11 - 11
1
2021 - 11 - 04
1
2021 - 09 - 28
1
2021 - 09 - 16
2
2021 - 08 - 30
1
2021 - 08 - 19
1
2021 - 08 - 09
1
2021 - 08 - 05
1
2021 - 08 - 02
1
2021 - 07 - 21
1
2021 - 06 - 17
1
2021 - 06 - 16
1
2021 - 06 - 03
1
2021 - 06 - 01
1
2021 - 05 - 12
1
2021 - 05 - 06
1
Crawled Time
00:00
74
00:01
1
00:20
9
01:00
112
01:15
1
02:00
23
02:11
1
03:00
13
04:00
5
04:20
9
05:00
13
06:00
11
07:00
13
08:00
22
09:00
19
10:00
31
10:51
1
11:00
111
11:36
1
12:00
173
12:03
2
12:07
5
12:09
2
12:10
1
12:11
7
12:15
19
12:20
29
12:30
19
12:34
1
12:39
1
12:40
1
13:00
100
13:01
1
13:07
1
13:15
8
13:20
25
13:30
11
14:00
77
14:15
8
14:20
11
14:30
18
15:00
84
15:15
3
15:20
22
15:30
19
16:00
95
16:20
11
17:00
67
18:00
60
18:17
2
18:31
2
19:00
53
19:11
2
20:00
46
20:20
3
21:00
94
22:00
70
22:04
2
23:00
52
23:07
2
Source
www.biospace.com
24
www.globenewswire.com
3
www.prnewswire.com
43
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
Lly
crawled time :
22:00
save search
Usher Syndrome Market to Exhibit Growth at a CAGR of 10.55% by 2034 | DelveInsight
Published:
2024-04-11
(Crawled : 22:00)
- prnewswire.com
ALPMF
|
News
|
$9.75
43.47%
200
|
Health Technology
|
-5.8%
|
O:
-100.0%
H:
NaN%
C:
Infinity%
ALPMY
|
News
|
$9.53
-1.11%
690K
|
Manufacturing
|
-7.39%
|
O:
-8.65%
H:
3.19%
C:
1.6%
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-1.05%
|
O:
-1.65%
H:
0.0%
C:
0.0%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
-3.72%
|
O:
-0.0%
H:
0.52%
C:
-1.04%
growth
market
Blacksmith Medicines To Highlight Preclinical Oncology Data Demonstrating a Potent and Selective FEN1 Inhibitor Has Synergy with Multiple DDR Drug Classes at AACR Annual Meeting 2024
Published:
2024-04-10
(Crawled : 22:00)
- biospace.com/
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
-3.42%
|
O:
-0.71%
H:
0.0%
C:
0.0%
drug
preclinical
meeting
Global Tissue Banking Market to Exhibit Growth at a Considerable CAGR of ~6% by 2030, Assesses DelveInsight
Published:
2024-04-09
(Crawled : 22:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-1.65%
|
O:
-0.01%
H:
0.0%
C:
0.0%
TMO
|
News
|
$574.59
4.78%
-1.12%
2.5M
|
Health Technology
|
-6.93%
|
O:
-2.01%
H:
0.0%
C:
0.0%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
-3.42%
|
O:
-0.71%
H:
0.0%
C:
0.0%
BIO
|
$285.28
1.84%
0.0%
230K
|
Health Technology
|
-17.48%
|
O:
-2.71%
H:
0.52%
C:
0.24%
AVTR
|
$25.65
5.08%
0.0%
5.6M
|
Process Industries
|
-5.61%
|
O:
-1.7%
H:
1.08%
C:
0.55%
THMO
|
$0.718
10.46%
9.47%
5.5K
|
Health Technology
|
-21.81%
|
O:
4.99%
H:
2.78%
C:
-2.1%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-2.64%
|
O:
-0.32%
H:
0.0%
C:
0.0%
global
growth
market
Giant-Cell Arteritis Market to Showcase Positive Growth at a CAGR of 9.3% by 2034 | DelveInsight
Published:
2024-04-08
(Crawled : 22:00)
- prnewswire.com
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-1.77%
|
O:
-0.3%
H:
0.0%
C:
0.0%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
-5.91%
|
O:
0.05%
H:
0.02%
C:
-2.62%
MOR
|
News
|
$18.04
0.45%
0.44%
180K
|
Health Technology
|
-0.99%
|
O:
0.06%
H:
0.22%
C:
0.0%
KNSA
|
$17.66
3.31%
3.2%
610K
|
Health Technology
|
-3.34%
|
O:
0.23%
H:
1.58%
C:
0.06%
IMAB
|
$1.81
0.56%
0.55%
200K
|
Health Technology
|
-0.55%
|
O:
-0.55%
H:
1.39%
C:
0.0%
GLPG
|
News
|
$29.47
1.38%
1.36%
120K
|
Health Technology
|
-8.76%
|
O:
0.0%
H:
0.39%
C:
-0.66%
positive
growth
market
Lilly Announces Details of Presentations at 2024 American Association for Cancer Research (AACR) Annual Meeting
Published:
2024-03-05
(Crawled : 22:00)
- prnewswire.com
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
-5.95%
|
O:
0.86%
H:
0.45%
C:
-0.58%
association
cancer
research
meeting
Proniras Corporation Secures New Series B Financing and Names New Board Members to Support Phase 1 Study of Novel Treatment for Opiate Withdrawal
Published:
2024-02-01
(Crawled : 22:00)
- biospace.com/
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
13.28%
|
O:
0.27%
H:
2.04%
C:
2.02%
corporation
series
treatment
study
Colposcopy Devices Global Market Likely to Exhibit Substantial Growth at a CAGR of ~5% by 2028, Predicts DelveInsight
Published:
2024-01-26
(Crawled : 22:00)
- prnewswire.com
PHG
|
News
|
$21.01
1.94%
0.0%
2M
|
Health Technology
|
Email alert
Add to watchlist
EVFM
|
$0.0159
-16.94%
160K
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
|
Email alert
Add to watchlist
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
Email alert
Add to watchlist
PKX
|
News
|
$71.48
-0.17%
0.0%
89K
|
Non-Energy Minerals
|
Email alert
Add to watchlist
global
growth
market
Vanda Pharmaceuticals announces the publication of an article on The Efficacy of Tradipitant in Patients with Diabetic and Idiopathic Gastroparesis in Phase III Randomized Placebo-Controlled Clinical Trial
Published:
2024-01-25
(Crawled : 22:00)
- biospace.com/
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
15.41%
|
O:
-1.0%
H:
0.84%
C:
0.04%
VNDA
|
$4.63
-3.54%
-3.67%
1.4M
|
Health Technology
|
37.74%
|
O:
2.72%
H:
0.53%
C:
0.53%
publication
pharmaceuticals
trial
diabetic
Drug-Eluting Balloons Global Market is Expected to Expand at a Healthy Growth Rate of ~8% by 2028, Predicts DelveInsight
Published:
2024-01-24
(Crawled : 22:00)
- prnewswire.com
TRUMF
|
$16.488
-17.59%
1.7K
|
Health Technology
|
-50.73%
|
O:
3.54%
H:
0.0%
C:
0.0%
TRUMY
|
$16.94
0.79%
52K
|
Manufacturing
|
-49.93%
|
O:
-0.3%
H:
0.18%
C:
-0.06%
PHG
|
News
|
$21.01
1.94%
0.0%
2M
|
Health Technology
|
-9.76%
|
O:
0.0%
H:
0.57%
C:
0.48%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
15.41%
|
O:
-1.0%
H:
0.84%
C:
0.04%
BSX
|
$68.99
1.43%
0.19%
9.1M
|
Health Technology
|
12.78%
|
O:
0.58%
H:
0.98%
C:
0.93%
SRDX
|
$26.85
5.75%
5.44%
53K
|
Health Technology
|
-27.04%
|
O:
1.03%
H:
0.0%
C:
-1.34%
expected
global
growth
market
CAR T-Cell Therapy Market to Register Stunning Growth During the Study Period (2019-2032) | DelveInsight
Published:
2024-01-23
(Crawled : 22:00)
- prnewswire.com
ACLX
|
$54.43
4.67%
4.46%
410K
|
|
-7.28%
|
O:
1.59%
H:
1.14%
C:
-1.42%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
16.14%
|
O:
0.61%
H:
1.52%
C:
0.03%
PSTX
|
$2.15
-0.23%
-0.23%
420K
|
Health Technology
|
-32.6%
|
O:
1.57%
H:
4.94%
C:
1.54%
INCY
|
$51.62
-0.58%
-0.58%
2.5M
|
Health Technology
|
-16.08%
|
O:
0.29%
H:
0.15%
C:
-1.95%
BEAM
|
$23.46
-2.66%
-2.73%
1.2M
|
Health Technology
|
-3.6%
|
O:
1.88%
H:
0.88%
C:
-2.79%
t-cell
therapy
growth
study
market
Non-Alcoholic Fatty Liver Disease Market to Observe Impressive Growth by 2032, Evaluates DelveInsight | Key Companies - MediciNova, Eli Lilly and Company, AstraZeneca, Madrigal Pharmaceuticals, BioMarin Pharmaceutical, GlaxoSmithKline, Pfizer
Published:
2024-01-22
(Crawled : 22:00)
- prnewswire.com
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
15.92%
|
O:
-0.51%
H:
0.37%
C:
0.32%
MDGL
|
$218.17
2.19%
2.15%
410K
|
Health Technology
|
-8.44%
|
O:
1.29%
H:
0.35%
C:
-3.04%
HEPA
|
$1.47
4.26%
4.08%
71K
|
Health Technology
|
-32.54%
|
O:
-0.48%
H:
7.69%
C:
1.44%
ALT
|
$7.56
1.21%
1.19%
3.1M
|
Commercial Services
|
-25.6%
|
O:
-0.8%
H:
6.02%
C:
0.6%
ALNY
|
$146.06
0.19%
0.18%
540K
|
Health Technology
|
-20.73%
|
O:
0.46%
H:
3.04%
C:
2.67%
ETNB
|
$8.92
-4.19%
-4.37%
750K
|
Health Technology
|
-14.74%
|
O:
1.19%
H:
0.63%
C:
-0.72%
liver
disease
companies
key
growth
market
AAV Vectors in Gene Therapy Market is Predicted to Observe Skyrocketed Growth During the Study Period (2019-2032) | DelveInsight `
Published:
2024-01-16
(Crawled : 22:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-10.78%
|
O:
-1.83%
H:
0.0%
C:
0.0%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
15.25%
|
O:
0.77%
H:
0.17%
C:
-1.65%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-10.44%
|
O:
0.45%
H:
0.06%
C:
-0.5%
RGNX
|
$15.885
1.57%
1.54%
360K
|
Health Technology
|
2.42%
|
O:
-0.13%
H:
0.0%
C:
-7.15%
ADVM
|
News
|
$10.96
-3.35%
-3.47%
310K
|
Health Technology
|
1305.2%
|
O:
-0.69%
H:
2.32%
C:
-0.12%
therapy
growth
study
market
Sjogren's Syndrome Market to Register Sustainable Growth During the Study Period (2019-2032), Predicts DelveInsight | Key Players - Horizon Therapeutics, Dompe Farmaceutici, MorphoSys, Resolve Therapeutics, Novartis, Johnson & Johnson
Published:
2024-01-16
(Crawled : 22:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-10.78%
|
O:
-1.83%
H:
0.0%
C:
0.0%
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-7.91%
|
O:
-1.02%
H:
0.0%
C:
0.0%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
15.25%
|
O:
0.77%
H:
0.17%
C:
-1.65%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-10.44%
|
O:
0.45%
H:
0.06%
C:
-0.5%
IMAB
|
$1.81
0.56%
0.55%
200K
|
Health Technology
|
-3.23%
|
O:
-1.08%
H:
0.0%
C:
-8.42%
resolve
key
growth
study
market
Heart Failure Treatment Drug Market to Accelerate Immensely by 2032, Predicts DelveInsight
Published:
2024-01-15
(Crawled : 22:00)
- prnewswire.com
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
13.75%
|
O:
0.15%
H:
0.59%
C:
-1.45%
drug
treatment
heart
market
Gene Therapy Global Market is Projected to Grow at a CAGR of ~19% by 2028, Predicts DelveInsight
Published:
2024-01-12
(Crawled : 22:00)
- prnewswire.com
TGTX
|
$14.25
1.06%
1.05%
3.2M
|
Health Technology
|
Email alert
Add to watchlist
VRTX
|
$404.93
1.25%
1.43%
1.1M
|
Health Technology
|
Email alert
Add to watchlist
RARE
F
|
$45.06
3.14%
3.04%
840K
|
Health Technology
|
Email alert
Add to watchlist
SLDB
|
$9.08
0.44%
0.44%
300K
|
Health Technology
|
Email alert
Add to watchlist
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
Email alert
Add to watchlist
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
News
|
$95.11
6.88%
490
|
Health Technology
|
Email alert
Add to watchlist
BLUE
|
$0.9739
2.13%
2.08%
4.8M
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
Email alert
Add to watchlist
DTIL
|
$10.33
6.72%
6.29%
31K
|
Health Technology
|
Email alert
Add to watchlist
global
therapy
market
Gastroenteropancreatic Neuroendocrine Tumors Market to Showcase a Significant Growth by 2032, Evaluates DelveInsight | Key Players - Eli Lilly and Company, Phanes Therapeutics, Camurus AB, Advanced Accelerator Applications, PharmaMar
Published:
2024-01-11
(Crawled : 22:00)
- prnewswire.com
RYZB
|
$62.49
0.03%
280K
|
|
1.11%
|
O:
0.21%
H:
0.0%
C:
0.0%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-11.92%
|
O:
0.71%
H:
0.0%
C:
0.0%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
15.04%
|
O:
0.39%
H:
0.91%
C:
0.74%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-11.59%
|
O:
0.06%
H:
0.0%
C:
0.0%
tumors
key
advanced
growth
market
Focal Segmental Glomerulosclerosis Market to Observe Impressive Growth by 2032, Predicts DelveInsight | Leading Companies - ACELYRIN, Genentech, ChemoCentryx, Travere Therapeutics, Boehringer Ingelheim, Chinook Therapeutics
Published:
2024-01-10
(Crawled : 22:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-10.95%
|
O:
1.1%
H:
0.0%
C:
0.0%
NVO
|
News
|
$128.64
2.7%
-0.07%
3.7M
|
Health Technology
|
15.27%
|
O:
-0.33%
H:
0.35%
C:
-1.5%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
16.05%
|
O:
0.67%
H:
0.85%
C:
0.21%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-10.98%
|
O:
0.69%
H:
0.0%
C:
0.0%
ALDX
|
$3.91
-0.51%
-0.51%
450K
|
Health Technology
|
17.66%
|
O:
-1.8%
H:
0.46%
C:
-2.44%
companies
therapeutics
growth
market
Lilly to Participate in J.P. Morgan Healthcare Conference - January 2, 2024
Published:
2024-01-02
(Crawled : 22:00)
- biospace.com/
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
25.46%
|
O:
-0.43%
H:
2.12%
C:
2.03%
conference
Metastatic Castration-Resistant Prostate Cancer Market is Predicted to Exhibit Remarkable Growth at a CAGR of 7.5% During the Study Period (2019-2032), Estimates DelveInsight
Published:
2023-12-20
(Crawled : 22:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-3.34%
|
O:
-0.1%
H:
0.0%
C:
0.0%
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-4.68%
|
O:
-1.87%
H:
0.0%
C:
0.0%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
28.26%
|
O:
0.21%
H:
0.63%
C:
0.1%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-5.12%
|
O:
-0.08%
H:
0.0%
C:
0.0%
cancer
growth
study
market
Metastatic Prostate Cancer Market to Exhibit Positive Growth at a CAGR of 22% and 7.5% for mHSPC and mCRPC, respectively During the Study Period (2019-2032), Assesses DelveInsight
Published:
2023-12-13
(Crawled : 22:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-3.35%
|
O:
0.25%
H:
0.0%
C:
0.0%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
25.4%
|
O:
1.8%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-4.19%
|
O:
0.0%
H:
0.0%
C:
0.0%
positive
cancer
growth
study
market
← Previous
1
2
3
4
Next →
Gainers vs Losers
78%
22%
Top 10 Gainers
MTTR
|
News
M
|
$4.6
164.37%
62.17%
28M
|
AGBA
|
$2.94
135.2%
57.48%
66M
|
Finance
EDBL
|
News
|
$6.46
71.81%
41.8%
2M
|
MTC
|
$2.25
44.23%
30.67%
6M
|
Technology Services
OPRT
|
News
|
$3.175
41.11%
29.13%
12M
|
Finance
SHIM
|
$3.05
35.56%
26.23%
1.1M
|
HKIT
|
$1.345
31.86%
24.16%
390K
|
Technology Services
ABVC
|
$1.36
30.77%
23.53%
7.4M
|
Wholesale Trade
OST
|
$0.512
28.0%
21.88%
290K
|
POET
|
$1.59
27.2%
21.38%
4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.